The reaction in question is essential for the biosynthesis of haemoglobin and chlorophyll, Wolfenden noted. But when catalyzed by the enzyme uroporphyrinogen decarboxylase, the rate of chlorophyll and haemoglobin production in cells "is increased by a staggering factor, one that's equivalent to the difference between the diameter of a bacterial cell and the distance from the Earth to the sun."
"This enzyme is essential for both plant and animal life on the planet," Wolfenden said.
"What we're defining here is what evolution had to overcome, that the enzyme is surmounting a tremendous obstacle, a reaction half-life of 2.3 billion years."
Knowing how long reactions would take without enzymes allows biologists to appreciate their evolution as prolific catalysts, Wolfenden said. It also enables scientists to compare enzymes with artificial catalysts produced in the laboratory.
"Without catalysts, there would be no life at all, from microbes to humans," he said.
"It makes you wonder how natural selection operated in such a way as to produce a protein that got off the ground as a primitive catalyst for such an extraordinarily slow reaction."
Experimental methods for observing very slow reactions can also generate important information for rational drug design based on cellular molecular studies.
"Enzymes that do a prodigious job of catalysis are, hands-down, the most sensitive targets for drug development," Wolfenden said.
"The enzymes we study are fascinating because they exceed all other known enzymes in their power as catalysts."
Wolfenden has carried out extensive research on enzyme mechanisms and water affinities of biological compound. His work has also influenced rational drug design, and findings from his laboratory helped spur development of ACE inhibitor drugs, now widely used to treat hypertension and stroke. Research on enzymes as proficient catalysts also led to the design of protease inhibitors that are used to treat HIV infection.
"We've only begun to understand how to speed up reactions with chemical catalysts, and no one has even come within shouting distance of producing, or predicting the magnitude of, their catalytic power," Wolfenden said.
Reference:
Uroporphyrinogen decarboxylation as a benchmark for the catalytic proficiency of enzymes
Charles A. Lewis, Jr. and Richard Wolfenden
PNAS, November 6, 2008, doi: 10.1073/pnas.0809838105
.........
ZenMaster For more on stem cells and cloning, go to CellNEWS at http://cellnews-blog.blogspot.com/ and http://www.geocities.com/giantfideli/index.html
No comments:
Post a Comment